Price T Rowe Associates Inc Sana Biotechnology, Inc. Transaction History
Price T Rowe Associates Inc
- $883 Billion
- Q2 2025
A detailed history of Price T Rowe Associates Inc transactions in Sana Biotechnology, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 2,557,825 shares of SANA stock, worth $7.95 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,557,825
Previous 2,654,138
3.63%
Holding current value
$7.95 Million
Previous $4.46 Million
56.59%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding SANA
# of Institutions
165Shares Held
108MCall Options Held
403KPut Options Held
295K-
Flagship Pioneering Inc. Cambridge, MA25MShares$77.8 Million26.7% of portfolio
-
Black Rock Inc. New York, NY11MShares$34.4 Million0.0% of portfolio
-
Canada Pension Plan Investment Board Toronto Ontario, A610.2MShares$31.6 Million0.03% of portfolio
-
Baillie Gifford & CO10.1MShares$31.3 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.61MShares$23.7 Million0.0% of portfolio
About Sana Biotechnology, Inc.
- Ticker SANA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 190,232,000
- Market Cap $592M
- Description
- Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others...